Incidence and factors associated with PrEP discontinuation in France.

Nina Garofoli Martin Siguier Olivier RobineauMichel ValetteBao PhungAntoine BachelardChristophe RiouxSylvie Le GacMarc DigumberGilles PialouxJade GhosnKaren Champenois

Published in: The Journal of antimicrobial chemotherapy (2024)

The incidence of PrEP discontinuations was quite low compared to rates observed in other cohorts. Users who stopped PrEP were sometimes still exposed to HIV, emphasizing the need for targeted interventions to prepare and support PrEP discontinuations and limit seroconversion risk.

Keyphrases

men who have sex with men
hiv testing
hiv positive
risk factors
antiretroviral therapy
human immunodeficiency virus
physical activity
hepatitis c virus
cancer therapy
hiv aids
drug delivery